The Cern Team

Jennifer Xavier


CERN Scientific Advisory Board

Jennifer Xavier

Associate Director of Research, Institute for Precision Medicine
Research Assistant Professor, Department of Pharmacology and Chemical Biology
University of Pittsburgh

Education

Undergraduate, Newcastle University, Newcastle Upon Tyne, UK (BSc)
Graduate, Institute for Cancer Therapeutics, University of Bradford, UK (PhD)
Postdoctoral Fellow, St Jude Children's Research Hospital, Memphis TN, USA
Postdoctoral Fellow, Eli Lilly and Company, Indianapolis, IN, USA

Research Interests

Dr. Xavier has a long standing interest in oncology drug discovery. During her time as a post doc in the lab of Dr. Richard Gilbertson at St. Jude Children's Research Hospital, she focused her efforts on high throughput screening to reveal FDA approved agents with potential application for the treatment of supratentorial ependymoma. Continuing her research in drug discovery, Dr. Xavier trained, and later led a research group, at Eli Lilly and Company, before returning to academic oncology drug discovery and cancer research. Currently, Dr. Xavier's research focuses on novel oncology drug target validation, and the clinical implementation of precision medicine.

Stay Informed with the CERN Newsletter

The CERN Foundation is committed to informing you with the latest ependymoma news and research. Join our mailing list for monthly updates.